The Australian medical landscape is abuzz with the introduction of retatrutide, a innovative dual GIP and GLP-1 receptor agonist showing impressive results in scientific trials for addressing obesity. https://sairatbud516478.canariblogs.com/retatrutide-australia-australia-a-new-hope-for-weight-loss-57127855